The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Nucleic Acid Testing to Detect HBV Infection in Blood Donors
Open accessAbstract
BACKGROUND: The detection of hepatitis B virus (HBV) in blood donors is achieved by screening for hepatitis B surface antigen (HBsAg) and for antibodies against hepatitis B core antigen (anti-HBc). However, donors who are positive for HBV DNA are currently not identified during the window period before seroconversion. The current use of nucleic acid testing for detection of the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) RNA and HBV DNA in a single triplex assay may provide additional safety. METHODS: We performed nucleic acid testing on 3.7 million blood donations and further evaluated those that were HBV DNA-positive but negative for HBsAg and anti-HBc. We determined the serologic, biochemical, and molecular features of samples that were found to contain only HBV DNA and performed similar analyses of follow-up samples and samples from sexual partners of infected donors. Seronegative HIV and HCV-positive donors were also studied. RESULTS: We identified 9 donors who were positive for HBV DNA (1 in 410,540 donations), including 6 samples from donors who had received the HBV vaccine, in whom subclinical infection had developed and resolved. Of the HBV DNA-positive donors, 4 probably acquired HBV infection from a chronically infected sexual partner. Clinically significant liver injury developed in 2 unvaccinated donors. In 5 of the 6 vaccinated donors, a non-A genotype was identified as the dominant strain, whereas subgenotype A2 (represented in the HBV vaccine) was the dominant strain in unvaccinated donors. Of 75 reactive nucleic acid test results identified in seronegative blood donations, 26 (9 HBV, 15 HCV, and 2 HIV) were confirmed as positive. CONCLUSIONS: Triplex nucleic acid testing detected potentially infectious HBV, along with HIV and HCV, during the window period before seroconversion. HBV vaccination appeared to be protective, with a breakthrough subclinical infection occurring with non-A2 HBV subgenotypes and causing clinically inconsequential outcomes. (Funded by the American Red Cross and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Raimondo, G., Allain, J.-P., Brunetto, M. R., Buendia, M.-A., Chen, D.-S., Colombo, M., Craxì, A., Donato, F., Ferrari, C., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 833
Self-citationStramer, S. L., Glynn, S. A., Kleinman, S. H., Strong, D. M., Caglioti, S., Wright, D. J., Dodd, R. Y., & Busch, M. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040085 · Cited by 536
Self-citationType B Hepatitis after Transfusion with Blood Containing Antibody to Hepatitis B Core Antigen
Hoofnagle, J. H., Seeff, L. B., Buskell‐Bales, Z., Zimmerman, H. J., & the Veterans Administration Hepatitis Cooperative Study Group* (1978) · New England Journal of Medicine · doi:10.1056/nejm197806222982502 · Cited by 458
Emerging infectious disease agents and their potential threat to transfusion safety
Stramer, S. L., Hollinger, F. B., Katz, L. M., Kleinman, S., Metzel, P. S., Gregory, K. R., & Dodd, R. Y. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02279.x · Cited by 427
Self-citationStevens, C. E., AACH, R. D., HOLLINGER, F. B., MOSLEY, J. W., SZMUNESS, W., KAHN, R., WERCH, J., & EDWARDS, V. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-733 · Cited by 302
Self-citationZou, S., Dorsey, K. A., Notari, E. P., Foster, G. A., Krysztof, D. E., Musavi, F., Dodd, R. Y., & Stramer, S. L. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02622.x · Cited by 288
Self-citationSatake, M., Taira, R., Yugi, H., Hino, S., Kanemitsu, K., Ikeda, H., & Tadokoro, K. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01276.x · Cited by 207
Occult hepatitis B virus infection: a covert operation
Hollinger, F. B., & Sood, G. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01245.x · Cited by 205
Self-citationHepatitis B virus infection and transfusion medicine: science and the occult
Hollinger, F. B. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01701.x · Cited by 197
Self-citationMosley, J. W., Stevens, C. E., Aach, R. D., Hollinger, F. B., Mimms, L. T., Solomon, L. R., Barbosa, L. H., & Nemo, G. J. (1995) · Transfusion · doi:10.1046/j.1537-2995.1995.35195090661.x · Cited by 137
Self-citationCurrent incidence and residual risk of hepatitis B infection among blood donors in the United States
Zou, S., Stramer, S. L., Notari, E. P., et al. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02195.x · Cited by 125
Self-citationPhelps, R. M., Robbins, K. E., Liberti, T. M., et al. (2004) · Transfusion · doi:10.1111/j.1537-2995.2004.03364.x · Cited by 74
Yoshikawa, A. L., Gotanda, Y., Minegishi, K., Taira, R., Hino, S., Tadokoro, K., Ohnuma, H., Miyakawa, K., Tachibana, K., & Mizoguchi, H. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01234.x · Cited by 69
Tabuchi, A., Tanaka, J., Katayama, K., Mizui, M., Matsukura, H., Yugi, H., Shimada, T., Miyakawa, Y., & Yoshizawa, H. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21320 · Cited by 61
Cited by
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Cornberg, M., Sandmann, L., Jaroszewicz, J., Kennedy, P., Lampertico, P., Lemoine, M., Lens, S., Testoni, B., Lai-Hung Wong, G., & Russo, F. P. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.03.018 · Cited by 437
Medical Virology of Hepatitis B: how it began and where we are now
Gerlich, W. H. (2013) · Virology Journal · doi:10.1186/1743-422x-10-239 · Cited by 349
Self-citationLevitsky, J., Formica, R. N., Bloom, R. D., Charlton, M., Curry, M., Friedewald, J., Friedman, J., Goldberg, D., Hall, S., Ison, M., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14381 · Cited by 327
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications
Pollicino, T., Cacciola, I., Saffioti, F., & Raimondo, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.041 · Cited by 277
Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kinetics
Ishida, Y., Chung, T. L., Imamura, M., Hiraga, N., Sen, S., Yokomichi, H., Tateno, C., Canini, L., Perelson, A. S., Uprichard, S. L., et al. (2018) · Hepatology · doi:10.1002/hep.29891 · Cited by 47
Metadata
- Authors
- Stramer, S. L., Wend, U., Candotti, D., Foster, G. A., Hollinger, F. B., Dodd, R. Y., Allain, J.-P., & Gerlich, W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-01-20
- Volume
- 364
- Issue
- 3
- Pages
- 236-247
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2147058388
- Cited by
- 326
- References
- 14
- FWCI
- 25.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.